Gonzales, Princess Jade .

HRN: 28-05-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
AMPICILLIN 1GM (VIAL)
11/17/2025
11/19/2025
IV
2 G
Every 6 Hours
Ruptured BOW
Waiting Final Action 
11/17/2025
CEFUROXIME 1.5GM (VIAL)
11/17/2025
11/17/2025
IV
1.5 G
Loading Dose
For CS
Waiting Final Action 
11/17/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
11/17/2025
11/20/2025
IV
240mg
ODX 4 Doses
Sp PLTCS
Waiting Final Action 
11/17/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/17/2025
11/19/2025
IV
900mg
Q8hr X 4 Doses
Sp PLTCS
Waiting Final Action 
11/17/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
ORAL
500mg
BID
Sp PLTCS
Waiting Final Action 
11/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/17/2025
11/19/2025
IV
500mg
Q8hr X 4 Doses
Sp PLTCS
Waiting Final Action 
11/17/2025
MUPIROCIN 2%, 15G (TUBE)
11/17/2025
11/23/2025
TOPICAL
15mg
BID X 7days
Sp PLTCS
Waiting Final Action 
11/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/19/2025
11/24/2025
IV
900mg
Q8hrs
S/P CS; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: